BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31451186)

  • 1. Coordinating Care Across the Perinatal Continuum in Hemolytic Disease of the Fetus and Newborn: The Timely Handoff of a Positive Maternal Anti-Erythrocyte Antibody Screen.
    Vats K; Watchko JF
    J Pediatr; 2019 Nov; 214():212-216. PubMed ID: 31451186
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability of anti-human serums in the detection of ABO hemolytic disease of the newborn, by means of the direct antiglobulin test.
    HABERMAN S; AGUILAR E; SOLOMON JM; TRIPP JT
    Am J Clin Pathol; 1960 Aug; 34():179-84. PubMed ID: 13830668
    [No Abstract]   [Full Text] [Related]  

  • 5. The reliability of anti-human serums in the detection of ABO hemolytic disease of the newborn, by means of the direct antiglobulin test.
    HABERMAN S; AGUILAR E; SOLOMON JM; TRIPP JT
    Tech Bull Regist Med Technol; 1960 Jul; 30():115-20. PubMed ID: 13830667
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
    Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid method for the determination of sensitized fetal red blood cells and maternal antibodies.
    MYHRE BA; GRAY M
    Am J Clin Pathol; 1960 Apr; 33():355-7. PubMed ID: 14425631
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S; Stefanović V; Capkun V
    Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO hemolytic disease. Serologic diagnosis with the two stage direct antiglobulin test, by means of fresh serum.
    CHAN AC; CHUNG F; KEITEL HG
    J Pediatr; 1962 Sep; 61():405-12. PubMed ID: 13877997
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal testing to predict the severity of hemolytic disease of the fetus and newborn.
    Contreras M; Garner SF; de Silva M
    Curr Opin Hematol; 1996 Nov; 3(6):480-4. PubMed ID: 9372121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic anemia in a newborn].
    UNGER LJ; WIENER AS; DOLAN D
    Rev Hematol; 1952; 7(4):495-504. PubMed ID: 13048105
    [No Abstract]   [Full Text] [Related]  

  • 13. Common hematologic problems in the newborn nursery.
    Watchko JF
    Pediatr Clin North Am; 2015 Apr; 62(2):509-24. PubMed ID: 25836711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn.
    Clark D; Greiss MA; Urbaniak SJ
    Br J Haematol; 1999 Sep; 106(3):824-6. PubMed ID: 10468880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic disease of the fetus and newborn: do not miss a positive maternal antierythrocyte antibody screen.
    Serra de Almeida N; Pinho C; Faim D; Henriques R
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34253518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the direct Coombs' test and the erythrocytic gelatin test in the diagnosis of hemolytic disease of the newborn].
    Mikhaĭlova AA
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):46-8. PubMed ID: 106380
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn.
    Gupta GK; Balbuena-Merle R; Hendrickson JE; Tormey CA
    Transfus Apher Sci; 2020 Oct; 59(5):102946. PubMed ID: 32962917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.